| Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR B Grubor-Bauk, A Simmons, G Mayrhofer, PG Speck The Journal of Immunology 170 (3), 1430-1434, 2003 | 257 | 2003 |
| Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection FJ Ryan, CM Hope, MG Masavuli, MA Lynn, ZA Mekonnen, AEL Yeow, ... BMC medicine 20, 1-23, 2022 | 187 | 2022 |
| Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines SHT Jorritsma, EJ Gowans, B Grubor-Bauk, DK Wijesundara Vaccine 34 (46), 5488-5494, 2016 | 126 | 2016 |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ... Cell reports Medicine 2 (4), 2021 | 74 | 2021 |
| Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice B Grubor-Bauk, JL Arthur, G Mayrhofer Journal of virology 82 (22), 11073-11083, 2008 | 67 | 2008 |
| NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice B Grubor-Bauk, DK Wijesundara, M Masavuli, P Abbink, RL Peterson, ... Science advances 5 (12), eaax2388, 2019 | 64 | 2019 |
| Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery D Christiansen, L Earnest-Silveira, B Grubor-Bauk, DK Wijesundara, I Boo, ... Scientific reports 9 (1), 9251, 2019 | 52 | 2019 |
| Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses H Balachandran, C Phetsouphanh, D Agapiou, A Adhikari, C Rodrigo, ... Cell reports 38 (6), 2022 | 39 | 2022 |
| Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine D Christiansen, L Earnest-Silveira, B Chua, P Meuleman, I Boo, ... Scientific reports 8 (1), 6483, 2018 | 37 | 2018 |
| Preclinical development and production of virus-like particles as vaccine candidates for hepatitis C MG Masavuli, DK Wijesundara, J Torresi, EJ Gowans, B Grubor-Bauk Frontiers in microbiology 8, 306782, 2017 | 37 | 2017 |
| A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice MG Masavuli, DK Wijesundara, A Underwood, D Christiansen, ... Frontiers in Immunology 10, 1145, 2019 | 32 | 2019 |
| Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs B Grubor-Bauk, W Yu, D Wijesundara, J Gummow, T Garrod, AJ Brennan, ... Gene therapy 23 (1), 26-37, 2016 | 32 | 2016 |
| A multiantigenic DNA vaccine that induces broad hepatitis C virus-specific T-cell responses in mice J Gummow, Y Li, W Yu, T Garrod, D Wijesundara, AJ Brennan, R Mullick, ... Journal of virology 89 (15), 7991-8002, 2015 | 31 | 2015 |
| Increase in DNA vaccine efficacy by virosome delivery and co‐expression of a cytolytic protein T Gargett, B Grubor‐Bauk, D Miller, T Garrod, S Yu, S Wesselingh, ... Clinical & translational immunology 3 (6), e18, 2014 | 30 | 2014 |
| Induction of antigen‐positive cell death by the expression of Perforin, but not DTa, from a DNA vaccine enhances the immune response T Gargett, B Grubor‐Bauk, TJ Garrod, W Yu, D Miller, L Major, ... Immunology and cell biology 92 (4), 359-367, 2014 | 30 | 2014 |
| SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents P Garcia-Valtanen, CM Hope, MG Masavuli, AEL Yeow, H Balachandran, ... Cell Reports Medicine 3 (6), 2022 | 29 | 2022 |
| DNA vaccines encoding membrane‐bound or secreted forms of heat shock protein 70 exhibit improved potency TJ Garrod, B Grubor‐Bauk, T Gargett, Y Li, DS Miller, W Yu, L Major, ... European Journal of Immunology 44 (7), 1992-2002, 2014 | 24 | 2014 |
| Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes S Roy, MI Jaeson, Z Li, S Mahboob, RJ Jackson, B Grubor-Bauk, ... Vaccine 37 (10), 1266-1276, 2019 | 23 | 2019 |
| Induction of genotype cross-reactive, hepatitis C virus-specific, cell-mediated immunity in DNA-vaccinated mice DK Wijesundara, J Gummow, Y Li, W Yu, BJ Quah, C Ranasinghe, ... Journal of virology 92 (8), 10.1128/jvi. 02133-17, 2018 | 23 | 2018 |
| A novel challenge model to evaluate the efficacy of hepatitis C virus vaccines in mice W Yu, B Grubor-Bauk, T Gargett, T Garrod, EJ Gowans Vaccine 32 (27), 3409-3416, 2014 | 21 | 2014 |
Eric GowansUniversity of AdelaideVerified email at adelaide.edu.au
